Ukraine has officially issued its first ever permit for medical cannabis to be imported into the country, bringing patients one step closer to receiving treatment. It represents the latest development in Ukraine’s nascent but rapidly evolving medical cannabis programme, after the country officially enshrined it into law [...]
Ahead of European Cannabis Week, Grow Group’s Managing Director, Pierre van Weperen, talks to Cannabis Health about the current state of play, and the future of cannabis-based medicine in the UK. More than 6.4 million people in the UK are currently waiting for treatment on the [...]
A national class action has been brought against Aurora Cannabis in Canada, alleging that the company ‘negligently’ failed to warn consumers about the risk of developing Cannabinoid Hyperemesis Syndrome (CHS). On May 14, 2025, the Ontario Superior Court of Justice certified a national class action alleging [...]
A profound change is quietly occurring across the UK, writes James Smith, medical cannabis patient and co-founder of 4C Labs, following a recent experience using cannabis-based medicines to recover from major hip surgery on the NHS. Disclaimer: I am not a doctor or a scientist, this [...]
A new UK study highlights how medical cannabis may improve quality of life for people living with obsessive compulsive disorder (OCD). Researchers at Drug Science analysed data from what they believe to be the largest sample of OCD patients receiving cannabis-based medicines on prescription. OCD is estimated [...]
Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical Diseases (PLOS NTDs), researchers discovered that Cannabidiol (CBD) and Cannabidivarin (CBDV) killed harmful Cryptococcus neoformans – a WHO-listed priority fungal pathogen. [...]
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products. Seven years since the first unlicensed cannabis-based medicinal products (CBPMs) were prescribed in the UK, the [...]
The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person. Its [...]
Cannabis use among older adults in the US has reached a new high, with 7% of adults aged 65 and over who report using it in the past month. This is according to an analysis led by researchers with the Center for Drug Use and HIV/HCV [...]
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical foundations. That means investing not just in science or access, but in a new generation of [...]
The UK government has rejected a petition calling for patients with a prescription for cannabis-based medicines to be allowed to grow their own plants at home. Around 13,000 people signed a petition calling for ‘Grow Your Own’ laws to allow patients with a prescription for cannabis-based [...]
The Medical Cannabis Clinicians Society (MCCS) has published its first comprehensive guidance specifically for pharmacy professionals involved in the dispensing of cannabis-based medicinal products (CBPMs) in the UK. Pharmacists play a vital role in the dispensing of CBPMs and have a responsibility to ensure these medications [...]
New research sheds light on the impact of cannabis legalisation on prescription drug claims following their implementation in the US. Approval of recreational and medical cannabis laws in most US states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically [...]
The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to cannabis. Europe’s first adult-use cannabis pilot programme, the Weed Care study, launched in Basel, Switzerland, in January 2023, to examine [...]
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’. First announced in November 2024, the medical cannabis bill (L135) has undergone an [...]
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A report published by Volteface in 2022 found that in the UK, while around 40,000 clinicians are eligible to prescribe medical cannabis, only [...]
The ‘remarkable’ mother and campaigner, who played a pivotal role in the legalisation of medical cannabis in the UK, Hannah Deacon, has died at the age of 45. In a statement on her website, Hannah’s loved ones said they were ‘heartbroken’ to share the news of [...]
New analysis from the UK has found that cannabis-based medicines are associated with improvements in symptoms and overall quality of life in patients with treatment-resistant epilepsy. Researchers say the study, which analysed data from the UK Medical Cannabis Registry (UKMCR), shows the ‘promising potential’ of cannabis-based [...]
After a six-year battle on behalf of campaigners, Romania’s Health Committee has rejected a bill which would broaden access to medical cannabis products on prescription. Following what has been described as “six years of silence”, in February, Romania’s Health Committee of the [...]
New research reveals that the use of cannabidiol (CBD) cannabis extract can lead to meaningful benefits and improve behaviour in children and teenagers with autism spectrum disorder (ASD). ASD affects approximately one in 100 children around the world and symptoms can include difficulty interpreting language, difficulty [...]
A new pilot study has examined how medically supervised cannabis use in a residential recovery home may support people in treatment for substance use challenges. The study, recently published in the Journal of Studies on Alcohol and Drugs, was conducted by researchers from UBC Okanagan and [...]
A cannabis executive is calling for law enforcement agencies to be better educated on medical cannabis, after a court ruled UK border force officers wrongfully seized his prescription. The managing director of the Canndr medical cannabis platform has spoken publicly for the first time after winning [...]
The largest meta-analysis of scientific data on medical cannabis’ viability in cancer treatment to date has been published, finding overwhelmingly positive consensus for its therapeutic potential. In a comprehensive review drawing on a dataset of over 10,000 peer-reviewed publications and nearly 40,000 associated data points, the Whole Health Oncology [...]
Patients prescribed medical cannabis in Australia maintained improvements in overall health-related quality of life (HRQL), fatigue, and sleep disturbance across a one-year period, according to new research. The study, published in the journal PLOS One by researchers at the University of Sydney, also found that anxiety, [...]
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner. This is even more important with the medical cannabis industry coming under closer scrutiny from regulators such as [...]
The number of pregnant women using cannabis in the US has more than tripled over the last two decades, with researchers calling for further studies to inform intervention approaches. Cannabis use has been increasing during pregnancy, according to researchers at Columbia University Mailman School of Public [...]
Scientists at the University of South Australia say they have developed an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases. Cannabidiol (CBD), the non-psychoactive compound found in the cannabis plant, is widely prescribed for its analgesic, anti-inflammatory [...]
France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised. Just weeks ago thousands of participants in Frances’ medical cannabis ‘experiment’, launched in 2021, were preparing to wean themselves off the treatment and had been instructed by the government to [...]
UK adults remain confused about the legal status and availability of medical cannabis, despite it being legalised in 2018, a new survey has revealed. According to a new study of 2,000 adults, while four in every five respondents (79%) were aware of medical cannabis, only 26% [...]
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines? While the number of prescriptions for CBMPs [...]
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over a year of warnings from various international health bodies and individual efforts from a swathe of countries [...]
A new study has found certain cannabis terpenes to be effective at relieving post-surgical and fibromyalgia pain in preclinical models. Research from the University of Arizona Health Sciences and funded by the National Institute of Health, suggests that terpenes from the Cannabis sativa plant may be [...]
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which permits them to purchase medical cannabis from any legal dispensary. Although the markets in Europe differ significantly to those in [...]
Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market evolves, established cannabis brands are playing an increasingly critical role in patient care, physician confidence, and regulatory acceptance, mirroring [...]
Scientists have developed a new compound to harnesses the pain-relieving properties of cannabis without any unwanted side effects, pointing to a possible alternative to opioids. In the search for alternative pain relievers, researchers at Washington University School of Medicine in St. Louis and Stanford University have [...]
In a new survey of UK doctors, 84% said they would be open to prescribing medical cannabis for chronic pain if it were part of the NHS toolkit. The findings indicate there may be significant support among doctors for widening access to medical cannabis for the [...]
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after Switzerland announced it was positioning itself to become the first European country to launch a full commercial adult-use [...]
In a new research paper, mothers using medical cannabis to manage their health say it helps them to be ‘more present’ and ‘tolerant’ parents. A new study, funded by the Health Research Council of New Zealand, has explored the experiences of mothers using medical cannabis to [...]
Drug policy experts have backed a family’s call for regulatory reform to protect patients travelling to Ireland with legal cannabis medication. Jason Pickering was making the trip to Ireland to visit his late father’s grave, when his cannabis medication was seized at Dublin Airport on 23 [...]
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the knowledge gaps and bring regulators on board? Regulators and medical professionals have repeatedly called for more [...]
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market, putting the country in pole position to be the first in Europe to do so. A new draft for a federal law, which would enable citizens to legally ‘grow, buy, possess and [...]
The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility has opened its doors to doctors, as its first products were made available on prescription for patients earlier this month. After five years and over £10 million in investment, Dalgety has become the first facility in the [...]
Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream healthcare has faced significant hurdles. While private clinics have provided access to cannabis-based medicines (CBMPs), many healthcare professionals remain sceptical, largely due to outdated perceptions, limited clinical education, and a lack [...]
A new research partnership between the University of Malta and the Authority for the Responsible Use of Cannabis will study the differences between illegal cannabis and that which is accessed through licensed associations. The agreement, which will see the University of Malta and the ARUC collaborate [...]
Europe’s first patient-led event will return next month with a focus on the medicinal use of cannabis in chronic neurodegenerative diseases. Following a successful launch in Madrid in October, We, The Patients, will host its first event in Switzerland on 1 March at the Resident Zürich [...]
Via Business of Cannabis Spain’s long-awaited medical cannabis program has finally taken a step forward as a draft of a Royal Decree has been sent to the European Union for approval. If approved, this should give Spanish patients legal access to medical cannabis for the first [...]
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van Heerden, a clinical doctor at Releaf with a background in emergency medicine, believes medical cannabis should be considered a first-line treatment option rather than an alternative. The Opioid Crisis: Over 500,000 [...]
New findings, from the largest study of its kind, suggest cannabis use may be linked to a decline in working memory among young adults. The new study published in JAMA Network Open explores the effects of both recent and lifetime cannabis use on brain function during [...]
Via Business of Cannabis The first parliamentary debate on medical cannabis in the UK under the new Labour administration has shattered hopes of a more progressive stance on reform. Despite impassioned speeches from members of various parties, unanimously calling for the UK’s ‘patchwork’ cannabis regulation to [...]
Canadian researchers have developed a unique method to allow for standardized cannabis dosing among different consumption methods. Researchers at UBC Okanagan have created an Index of Cannabis Equivalence (ICE), a unique approach to standardized cannabis dosing across different consumption methods. Published in the Journal of Psychoactive [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
